<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="168024">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01726699</url>
  </required_header>
  <id_info>
    <org_study_id>12-6011</org_study_id>
    <nct_id>NCT01726699</nct_id>
  </id_info>
  <brief_title>Scripps Tumorgraft Study</brief_title>
  <official_title>Scripps Tumorgraft Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Scripps Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Scripps Translational Science Institute</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study the genetic traits of cancerous tissues and to help improve cancer treatment by
      developing tumor models for studying new cancer drugs.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Facilitate the development of individualized tumorgraft models for many different types of cancer.</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Solid Tumor Malignancy or Hematologic Malignancy</condition>
  <arm_group>
    <arm_group_label>Cancer Diagnosis</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and tissue samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with a solid tumor malignancy or a hematologic malignancy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 21 or over

          -  diagnosis of a solid tumor malignancy, either resectable or metastatic or a
             hematologic malignancy

          -  cognitively and emotionally able to give informed consent

        Exclusion Criteria:

          -  Under age 21

          -  Not cognitively or emotionally able to give informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Goetz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director, Applied Genetic Epidemiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sharon Haaser, RN, BSN</last_name>
    <phone>858-554-5758</phone>
    <email>haaser.sharon@scrippshealth.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Scripps Translational Science Institute</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Haaser, RN, BSN</last_name>
      <phone>858-554-5758</phone>
      <email>haaser.sharon@scrippshealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 6, 2014</lastchanged_date>
  <firstreceived_date>November 6, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Scripps Translational Science Institute</investigator_affiliation>
    <investigator_full_name>Laura Goetz, M.D.</investigator_full_name>
    <investigator_title>Director, Applied Genetic Epidemiology</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Hematologic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
